Certain group of individuals are listed by the government agency in their website which will acquire first the vaccine. It starts from pregnant woman, infants and to adults.
People may now curious about the vaccine but according to the agency website, there's no need to worry about the shortage of the vaccine because they already have a second set of options if this thing might able to happen.
The committee recognized the need to assess supply and demand issues at the local level. The committee further recommended that once the demand for vaccine for these target groups has been met at the local level, programs and providers should begin vaccinating everyone from ages 25 through 64 years. Current studies indicate the risk for infection among persons age 65 or older is less than the risk for younger age groups. Therefore, as vaccine supply and demand for vaccine among younger age groups is being met, programs and providers should offer vaccination to people over the age of 65.Inquire to your local medical institution for the availability of N1H1 Vaccine in your local community to be informed more. The CDC's website offers a few tips and recommendations about the incoming release of the vaccine to public.
